VICKS FORMULA 44 Drug Patent Profile
✉ Email this page to a colleague
When do Vicks Formula 44 patents expire, and what generic alternatives are available?
Vicks Formula 44 is a drug marketed by Warner Chilcott and is included in one NDA.
The generic ingredient in VICKS FORMULA 44 is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vicks Formula 44
A generic version of VICKS FORMULA 44 was approved as diphenhydramine hydrochloride by WEST-WARD PHARMS INT on December 31st, 1969.
Summary for VICKS FORMULA 44
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 136 |
| Clinical Trials: | 794 |
| Patent Applications: | 4,356 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | VICKS FORMULA 44 at DailyMed |
Recent Clinical Trials for VICKS FORMULA 44
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Science and Technology Council | Phase 2 |
| The Third Affiliated Hospital of Henan University of Traditional Chinese Medicine | N/A |
| The First Affiliated Hospital of Henan University of Traditional Chinese Medicine | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for VICKS FORMULA 44
US Patents and Regulatory Information for VICKS FORMULA 44
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Warner Chilcott | VICKS FORMULA 44 | diphenhydramine hydrochloride | SYRUP;ORAL | 070524-001 | Jan 14, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
